Cryptic polyreactivity of IgG expressed by splenic marginal zone B-cell lymphoma

Molecular Immunology

Volumn 60, Issue 1, 2014, Pages 54-61

  Mahendra, Ankit ^a,b,c,d   Gangadharan, Bagirath ^a,b,c   André, Sébastien ^a,b,c   Boudjoghra, Myriam ^e   Davi, Frédéric ^b,e   Lecerf, Maxime ^a,b,c   Planchais, Cyril ^a,b,c   Kaveri, Srinivas V ^a,b,c   Lacroix Desmazes, Sébastien ^a,b,c   Dimitrov, Jordan D ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Antibody polyreactivity; B cell lymphoma; Heme; Hemolysis; Immunoglobulins

Indexed keywords

AUTOANTIGEN; B LYMPHOCYTE RECEPTOR; BLOOD CLOTTING FACTOR 9; COMPLEMENT FACTOR H; HEMATIN; HEME; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIGEN RECEPTOR; N (8 AMINO 1 CARBOXYOCTYL)ALANYLPROLINE; PROTEIN G; REACTIVE OXYGEN METABOLITE; TUBULIN;

ADULT; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MIDDLE AGED; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLENIC MARGINAL ZONE LYMPHOMA; SURFACE PLASMON RESONANCE; WESTERN BLOTTING;

ANTIBODY POLYREACTIVITY; B CELL LYMPHOMA; HEME; HEMOLYSIS; IMMUNOGLOBULINS;

AMINO ACID SEQUENCE; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIGENS; BASE SEQUENCE; CELLS, CULTURED; DIPEPTIDES; FEMALE; HEMIN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN VARIABLE REGION; INFLAMMATION; LYMPHOMA, B-CELL, MARGINAL ZONE; MIDDLE AGED; RECEPTORS, ANTIGEN, B-CELL; SEQUENCE ANALYSIS, DNA;

EID: 84899150270     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.03.009     Document Type: Article

References (43)

1. Balla J., Jacob H.S., Balla G., Nath K., Eaton J.W., Vercellotti G.M. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:9285-9289.
2. Bergstra T.J., Smeets K., Nieuwland M.G., Parmentier H.K. In vivo and in vitro post-translational polymorphism of chicken natural auto-antibodies. Dev. Comp. Immunol. 2010, 34:821-827.
3. Borche L., Lim A., Binet J.L., Dighiero G. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 1990, 76:562-569.
4. Burger J.A., Chiorazzi N. B cell receptor signaling in chronic lymphocytic leukemia. Trends Immunol. 2013, 34:592-601.
5. Chu C.C., Catera R., Hatzi K., Yan X.J., Zhang L., Wang X.B., Fales H.M., Allen S.L., Kolitz J.E., Rai K.R., Chiorazzi N. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA. Blood 2008, 112:5122-5129.
6. Craig V.J., Arnold I., Gerke C., Huynh M.Q., Wundisch T., Neubauer A., Renner C., Falkow S., Muller A. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood 2010, 115:581-591.
7. Craig V.J., Cogliatti S.B., Arnold I., Gerke C., Balandat J.E., Wundisch T., Muller A. B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis. Leukemia 2010, 24:1186-1196.
8. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., Buchbinder A., Budman D., Dittmar K., Kolitz J., Lichtman S.M., Schulman P., Vinciguerra V.P., Rai K.R., Ferrarini M., Chiorazzi N. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-1847.
9. Darley-Usmar V., Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm. Res. 1996, 13:649-662.
10. Dimitrov J.D., Ivanovska N.D., Lacroix-Desmazes S., Doltchinkova V.R., Kaveri S.V., Vassilev T.L. Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G. J. Biol. Chem. 2006, 281:439-446.
11. Dimitrov J.D., Pashov A., Vassilev T.L. Antibody polyspecificity: what does it matter?. Landes Bioscience 2012, Springer. H. Lutz (Ed.).
12. Dimitrov J.D., Planchais C., Roumenina L.T., Vassilev T.L., Kaveri S.V., Lacroix-Desmazes S. Antibody polyreactivity in health and disease: statu variabilis. J. Immunol. 2013, 191:993-999.
13. Dimitrov J.D., Roumenina L.T., Doltchinkova V.R., Mihaylova N.M., Lacroix-Desmazes S., Kaveri S.V., Vassilev T.L. Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions. J. Biol. Chem. 2007, 282:26696-26706.
14. Dimitrov J.D., Vassilev T.L. Cofactor-mediated protein promiscuity. Nat. Biotechnol. 2009, 27:892.
15. Djoumerska-Alexieva I.K., Dimitrov J.D., Nacheva J., Kaveri S.V., Vassilev T.L. Protein destabilizing agents induce polyreactivity and enhanced immunomodulatory activity in IVIg preparations. Autoimmunity 2009, 42:365-367.
16. Elkon K.B., Silverman G.J. Naturally occurring autoantibodies to apoptotic cells. Adv. Exp. Med. Biol. 2012, 750:14-26.
17. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L., Schulman P., Vinciguerra V.P., Rai K., Rassenti L.Z., Kipps T.J., Dighiero G., Schroeder H.W., Ferrarini M., Chiorazzi N. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 1998, 102:1515-1525.
18. Franco V., Florena A.M., Iannitto E. Splenic marginal zone lymphoma. Blood 2003, 101:2464-2472.
19. Frimat M., Tabarin F., Dimitrov J.D., Poitou C., Halbwachs-Mecarelli L., Fremeaux-Bacchi V., Roumenina L.T. Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome. Blood 2013, 122:282-292.
20. Ghiotto F., Fais F., Valetto A., Albesiano E., Hashimoto S., Dono M., Ikematsu H., Allen S.L., Kolitz J., Rai K.R., Nardini M., Tramontano A., Ferrarini M., Chiorazzi N. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J. Clin. Invest. 2004, 113:1008-1016.
21. Grabar P. Hypothesis. Auto-antibodies and immunological theories: an analytical review. Clin. Immunol. Immunopathol. 1975, 4:453-466.
22. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94:1848-1854.
23. Herve M., Xu K., Ng Y.S., Wardemann H., Albesiano E., Messmer B.T., Chiorazzi N., Meffre E. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J. Clin. Invest. 2005, 115:1636-1643.
24. Kumar S., Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 2005, 157:175-188.
25. Lanemo Myhrinder A., Hellqvist E., Sidorova E., Soderberg A., Baxendale H., Dahle C., Willander K., Tobin G., Backman E., Soderberg O., Rosenquist R., Horkko S., Rosen A. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 2008, 111:3838-3848.
26. Lutz H.U. Homeostatic roles of naturally occurring antibodies: an overview. J. Autoimmun. 2007, 29:287-294.
27. Mauro F.R., Foa R., Cerretti R., Giannarelli D., Coluzzi S., Mandelli F., Girelli G. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood 2000, 95:2786-2792.
28. McIntyre J.A. The appearance and disappearance of antiphospholipid autoantibodies subsequent to oxidation-reduction reactions. Thromb. Res. 2004, 114:579-587.
29. McIntyre J.A., Wagenknecht D.R., Faulk W.P. Autoantibodies unmasked by redox reactions. J. Autoimmun. 2005, 24:311-317.
30. McIntyre J.A., Wagenknecht D.R., Faulk W.P. Redox-reactive autoantibodies: detection and physiological relevance. Autoimmun. Rev. 2006, 5:76-83.
31. Mihaylova N.M., Dimitrov J.D., Djoumerska-Alexieva I.K., Vassilev T.L. Inflammation-induced enhancement of IgG immunoreactivity. Inflamm. Res. 2008, 57:1-3.
32. Muller-Eberhard U., Javid J., Liem H.H., Hanstein A., Hanna M. Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood 1968, 32:811-815.
33. Notkins A.L. Polyreactivity of antibody molecules. Trends Immunol. 2004, 25:174-179.
34. Ochsenbein A.F., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., Zinkernagel R.M. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999, 286:2156-2159.
35. Omersel J., Jurgec I., Cucnik S., Kveder T., Rozman B., Sodin-Semrl S., Bozic B. Autoimmune and proinflammatory activity of oxidized immunoglobulins. Autoimmun. Rev. 2008, 7:523-529.
36. Repesse Y., Dimitrov J.D., Peyron I., Farrokhi Moshai E., Kiger L., Dasgupta S., Delignat S., Marden M.C., Kaveri S.V., Lacroix-Desmazes S. Heme binds to factor VIII and inhibits its interaction with activated factor IX. J. Thromb. Haemost. 2012, 10:1062-1071.
37. Roumenina L.T., Radanova M., Atanasov B.P., Popov K.T., Kaveri S.V., Lacroix-Desmazes S., Fremeaux-Bacchi V., Dimitrov J.D. Heme interacts with c1q and inhibits the classical complement pathway. J. Biol. Chem. 2011, 286:16459-16469.
38. Sthoeger Z.M., Wakai M., Tse D.B., Vinciguerra V.P., Allen S.L., Budman D.R., Lichtman S.M., Schulman P., Weiselberg L.R., Chiorazzi N. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J. Exp. Med. 1989, 169:255-268.
39. van Dongen J.J., Langerak A.W., Bruggemann M., Evans P.A., Hummel M., Lavender F.L., Delabesse E., Davi F., Schuuring E., Garcia-Sanz R., van Krieken J.H., Droese J., Gonzalez D., Bastard C., White H.E., Spaargaren M., Gonzalez M., Parreira A., Smith J.L., Morgan G.J., Kneba M., Macintyre E.A. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 2003, 17:2257-2317.
40. Wagener F.A., Volk H.D., Willis D., Abraham N.G., Soares M.P., Adema G.J., Figdor C.G. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 2003, 55:551-571.
41. Warsame A.A., Aasheim H.C., Nustad K., Troen G., Tierens A., Wang V., Randen U., Dong H.P., Heim S., Brech A., Delabie J. Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity. Blood 2011, 118:3331-3339.
42. Zhou Z.H., Tzioufas A.G., Notkins A.L. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J. Autoimmun. 2007, 29:219-228.
43. Zhou Z.H., Zhang Y., Hu Y.F., Wahl L.M., Cisar J.O., Notkins A.L. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 2007, 1:51-61.